English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 11, 2025

American Lung Association criticizes EPA's proposed rollback on carbon emission standards
+ Pharmaceuticals
Patient Daily | Jun 10, 2025

Radiation oncologist on 340B program: ‘It is used as a consolidation tool by large institutions to kill competition in the market’
+ Pharmaceuticals
Patient Daily | Jun 10, 2025

Martin Kang receives joint research award from ATS and ALA
+ Pharmaceuticals
Patient Daily | Jun 10, 2025

Dehydration risks rise as summer heats up: expert advice on prevention
+ Pharmaceuticals
Patient Daily | Jun 9, 2025

Director of Public Affairs of PhRMA: ‘There is also evidence that 340B is harming state and federal budgets’
+ Pharmaceuticals
Patient Daily | Jun 9, 2025

UTHealth Houston offers free tuition for qualifying nursing students
+ Pharmaceuticals
Patient Daily | Jun 9, 2025

Grayslake hosts children's health fair focused on safety education
+ Pharmaceuticals
Patient Daily | Jun 9, 2025

Patient advocacy groups criticize House-passed H.R.1 over potential loss of health coverage

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes